Resources with keywords: anti-viral treatments



Viral burden rebound in hospitalised patients with COVID-19 receiving oral antivirals in Hong Kong: a population-wide retrospective cohort study (Website)
The Lancet: Infectious Diseases
13 February 2023

The Lancet: Viral burden rebound in hospitalised patients with COVID-19 receiving oral antivirals in Hong Kong: a population-wide retrospective cohort study. Wong, C., et.al. (Feb 13, 2023)

Wong, C., et.al.
Viral burden rebound rates are similar between patients with antiviral treatment and those without. Importantly, viral burden rebound was not associated with adverse clinical outcomes.

Go to Top